
A panel of external experts has advised the American Food and Drug Administration (FDA) to approve over-the-counter sales of naloxone nasal spray.
Naloxone is an affordable and risk-free way to save drug users from an overdose. The spray costs $250 without insurance and prevents deaths from fentanyl, heroin and painkillers. Naloxone has no effect on people who are sober.
Only 29 states allow pharmacists to sell naloxone without a prescription. Even in the states that allow over-the-counter sales, there isn’t enough of the stuff. A study published in The Lancet estimates that 1,270 more naloxone kits are needed for every 100,000 residents to avoid 80 percent of opioid overdose deaths. (more…)











